Details
Stereochemistry | RACEMIC |
Molecular Formula | C15H25NO3 |
Molecular Weight | 267.3639 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COCCC1=CC=C(OCC(O)CNC(C)C)C=C1
InChI
InChIKey=IUBSYMUCCVWXPE-UHFFFAOYSA-N
InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3
Molecular Formula | C15H25NO3 |
Molecular Weight | 267.3639 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:30:20 UTC 2023
by
admin
on
Sat Dec 16 16:30:20 UTC 2023
|
Record UNII |
GEB06NHM23
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
C07FX03
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
WHO-ATC |
C07BB52
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
LIVERTOX |
NBK547984
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
WHO-ATC |
C07BB02
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
FDA ORPHAN DRUG |
804220
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
WHO-ATC |
C07AB02
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
WHO-VATC |
QC07BB02
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
WHO-ATC |
C07FB02
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
WHO-ATC |
C07CB02
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
WHO-VATC |
QC07AB02
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
WHO-ATC |
C07FX05
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
WHO-VATC |
QC07AB52
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
NDF-RT |
N0000175556
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
WHO-VATC |
QC07CB02
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
WHO-VATC |
QC07FB02
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
NDF-RT |
N0000000161
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
WHO-ATC |
C07AB52
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
NCI_THESAURUS |
C29576
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
FDA ORPHAN DRUG |
804320
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
WHO-VATC |
QC07BB52
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
||
|
WHO-ATC |
C07FB13
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
253-483-7
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
ALTERNATIVE | |||
|
51384-51-1
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
METOPROLOL
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
GEB06NHM23
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
257-166-4
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
DTXSID2023309
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
37350-58-6
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
SUPERSEDED | |||
|
100000076066
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
D008790
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
Metoprolol
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
CHEMBL13
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
GEB06NHM23
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
6918
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | RxNorm | ||
|
DB00264
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
6904
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
6531
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
553
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
SUB14568MIG
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
m7498
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | Merck Index | ||
|
1786
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
C61845
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
3471
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY | |||
|
54163-88-1
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
SUPERSEDED | |||
|
4171
Created by
admin on Sat Dec 16 16:30:23 UTC 2023 , Edited by admin on Sat Dec 16 16:30:23 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> AGONIST |
SHORT-ACTING
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> SUBSTRATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
O-demethylmetoprolol is a pharmacologically active urinary metoprolol metabolite that has 5 to 10X less potent than metoprolol.
|
||
|
METABOLITE INACTIVE -> PARENT |
URINE
|
||
|
METABOLITE ACTIVE -> PARENT |
Alpha-hydroxymetoprololhas 5 to 10X less potent than metoprolol.
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
Elimination PHARMACOKINETIC PHARMACOKINETIC |
|
||